While eating, I chatted with Teacher Tan about research.
Teacher Tan is an expert in laparoscopic procedures, as well as a specialist in general surgery and gastrointestinal tumor surgery. Teacher Tan’s traditional surgical methods and laparoscopic techniques are equally top-notch, and his treatment plans for tumor patients outside of surgery are also first-rate.
It is laughable to imagine that the scope of academic research Teacher Tan can perform is limited to laparoscopic procedures. It’s like the Immortal Brother rarely performs heart transplant surgeries but studies auxiliary devices for end-stage heart treatment.
For a surgeon, conducting research, surgery is an advantage, reflected in the ability to study various surgeries. On the other hand, in basic academic fields, surgeons have an advantage primarily due to the pathology specimens they collect.
Surgeons find it exceedingly easy to capture various surgical pathology specimens of patients’ tumors during surgery. Unlike other departments, where obtaining desired pathology specimens is extremely difficult. The specimens acquired through internal medicine endoscopy are limited in scope and far inferior to those obtained in surgery. This way, you’ll find that surgeons doing basic research can be comparable to, or sometimes even better than, internal medicine physicians and pathologists.
Teacher Tan happens to be such a Boss.
Specifically, regarding the topics Teacher Tan researches, it could be said he studies highly famous antitumor drugs that emerged after entering the 21st century: targeted drugs.
Targeted drugs are like arrows aiming at tumors "thwack-thwack", compared to chemotherapy drugs attacking tumors like spraying insecticides, with high precision to avoid harming healthy body tissues, thus warmly welcomed by doctors and patients. The advantage of targeted drugs lies in precision, the foundation of accuracy for targeted drugs lies in the target point, so identifying the target point for targeted drugs naturally becomes the top priority for researchers.
The essence of researching target points is inseparable from studying the tumor pathogenesis.
The pathogenesis of tumors is complex, involving numerous elements and substances that can theoretically become target points, such as the most common ones: receptors, transporters, enzymes, ion channels, genes, etc., many of which have been constantly researched as basic topics. Here is a relatively new research topic discovered and proposed in recent years, called MicroRNA.
MicroRNA, in simple terms, can be likened to substances in the intestinal flora. Good MicroRNA absorbed by humans can inhibit tumor tissue. Bad MicroRNA will promote the growth of tumor tissue. Based on this principle, if medical oncology research focuses on the former, it can become a tumor suppressor. To counter the latter bad entities, developing "thwack-thwack" targeted drugs is most appropriate.
Medical discovery shows simply inhibiting tumors is not as effective as declaring an all-out assault. The forefront of targeted drugs against MicroRNA, according to the information Xie Wanying, who traveled back from the future, knows, belongs to the future trend of targeted drugs.
Regardless of how, as mentioned earlier, to develop targeted drugs one must first locate the target point, and to do RNA targeted drugs one must identify the MicroRNA. Teacher Tan’s key research project is studying colon cancer MicroRNA. He discovered a brand new MicroRNA among a wide range of colon cancer specimens, theoretically capable of becoming the target point of new targeted drugs for colon cancer, placing it at the forefront of the world’s tumor research field.
Teacher Tan’s research project is so cutting-edge that Xie Wanying definitely says she cannot criticize the teacher’s research.